CA2904418A1 - Tests et procedes de selection d'un regime de traitement pour un sujet atteint de depression - Google Patents

Tests et procedes de selection d'un regime de traitement pour un sujet atteint de depression Download PDF

Info

Publication number
CA2904418A1
CA2904418A1 CA2904418A CA2904418A CA2904418A1 CA 2904418 A1 CA2904418 A1 CA 2904418A1 CA 2904418 A CA2904418 A CA 2904418A CA 2904418 A CA2904418 A CA 2904418A CA 2904418 A1 CA2904418 A1 CA 2904418A1
Authority
CA
Canada
Prior art keywords
seq
snp
identified
complement
folate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2904418A
Other languages
English (en)
Inventor
Maurizio Fava
George PAPAKOSTAS
Harold O. Koch, Jr.
David KRONLAGE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/796,362 external-priority patent/US9546401B2/en
Application filed by Nestec SA filed Critical Nestec SA
Publication of CA2904418A1 publication Critical patent/CA2904418A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2904418A 2013-03-12 2014-03-11 Tests et procedes de selection d'un regime de traitement pour un sujet atteint de depression Abandoned CA2904418A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361777650P 2013-03-12 2013-03-12
US61/777,650 2013-03-12
US13/796,362 2013-03-12
US13/796,362 US9546401B2 (en) 2011-11-14 2013-03-12 Assays and methods for selecting a treatment regimen for a subject with depression
US201361914338P 2013-12-10 2013-12-10
US61/914,338 2013-12-10
PCT/US2014/023695 WO2014164882A1 (fr) 2013-03-12 2014-03-11 Tests et procédés de sélection d'un régime de traitement pour un sujet atteint de dépression

Publications (1)

Publication Number Publication Date
CA2904418A1 true CA2904418A1 (fr) 2014-10-09

Family

ID=51658998

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2904418A Abandoned CA2904418A1 (fr) 2013-03-12 2014-03-11 Tests et procedes de selection d'un regime de traitement pour un sujet atteint de depression

Country Status (12)

Country Link
EP (1) EP2973135A4 (fr)
JP (1) JP2016518816A (fr)
KR (1) KR20150131147A (fr)
CN (1) CN105518685A (fr)
AU (1) AU2014248949A1 (fr)
BR (1) BR112015022820A8 (fr)
CA (1) CA2904418A1 (fr)
IL (1) IL241156A0 (fr)
MX (1) MX2015012520A (fr)
RU (1) RU2015143177A (fr)
TW (1) TW201437635A (fr)
WO (1) WO2014164882A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2855706A4 (fr) * 2012-06-01 2016-06-08 Brc Operations Pty Ltd Biomaqueurs pour résultats thérapeutiques
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3229812A4 (fr) 2014-12-08 2018-10-03 Glycom A/S Composition synthétique pour le traitement de troubles métaboliques
WO2016135707A1 (fr) * 2015-02-27 2016-09-01 Nestec S.A. Diagnostic de trouble dépressif majeur, de déficience cognitive légère, et de la maladie d'alzheimer et d'autres troubles neurologiques et psychiatriques
US10835545B2 (en) 2015-10-28 2020-11-17 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
EP3368047B1 (fr) 2015-10-28 2023-04-26 Glycom A/S Composition synthétique et procédé de modulation des troubles émotionnels et de l'humeur
KR101911339B1 (ko) * 2017-07-17 2018-10-25 고려대학교 산학협력단 카테콜아민-o-메틸 전이 효소 유전자의 메틸화 비율을 이용한 우울증 진단에 관한 정보를 제공하는 방법
US20210268468A1 (en) * 2018-07-12 2021-09-02 Korea Research Institute Of Bioscience And Biotechnology Substrate for nucleic acid amplification, and method for manufacturing same
CN109234383A (zh) * 2018-11-07 2019-01-18 上海康黎医学检验所有限公司 与抗精神疾病药相关的试剂盒、目标基因及其制备、snp标记、snp识别和应用
CN109966498A (zh) * 2019-03-25 2019-07-05 北京坤秋健康科技有限公司 一种抗抑郁症的药物组合物及其用途
CN111500709A (zh) * 2020-05-12 2020-08-07 珠海横琴润孚创新科技有限公司 一种代谢性疾病基因检测与临床深度数据分析方法
KR102570458B1 (ko) * 2021-01-21 2023-08-24 전남대학교산학협력단 여성의 우울증 위험도 예측용 바이오마커, 상기 바이오마커를 이용한 여성의 우울증 위험도 진단에 대한 정보제공방법 및 진단키트
JP7432190B2 (ja) * 2021-03-01 2024-02-16 勝彦 山▲崎▼ 抗うつ薬抵抗性の大うつ病患者を識別するための、データの取得方法およびキット
CN116103385A (zh) * 2021-11-11 2023-05-12 中国科学院深圳理工大学(筹) 一种预测抑郁障碍患者对治疗反应的基因诊断试剂盒和系统
WO2023237306A1 (fr) 2022-06-09 2023-12-14 Dsm Ip Assets B.V. Composition nutritionnelle comprenant des gos et des hmo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060216737A1 (en) * 2005-03-10 2006-09-28 John Bodeau Methods for multiplex amplification
EP2435586A4 (fr) * 2009-05-29 2012-12-26 Genomind Llc Méthodes d'évaluation et de traitement de la dépression via l'utilisation d'une analyse des polymorphismes nucléotidiques simples
US20120115147A1 (en) * 2010-11-05 2012-05-10 Lombard Jay L Neuropsychiatric test reports
AU2010300475A1 (en) * 2009-09-30 2012-05-03 The Regents Of The University Of California Cofactors and methods for use for individuals
WO2012128799A2 (fr) * 2010-12-03 2012-09-27 General Hospital Corporation, The Traitement de la schizophrénie
MX354547B (es) * 2011-11-14 2018-03-09 Alfasigma Spa Ensayos y métodos para seleccionar un regimen de tratamiento para un sujeto con depresión.

Also Published As

Publication number Publication date
CN105518685A (zh) 2016-04-20
KR20150131147A (ko) 2015-11-24
JP2016518816A (ja) 2016-06-30
TW201437635A (zh) 2014-10-01
EP2973135A4 (fr) 2016-11-16
IL241156A0 (en) 2015-11-30
WO2014164882A1 (fr) 2014-10-09
MX2015012520A (es) 2016-01-12
BR112015022820A8 (pt) 2019-11-26
AU2014248949A1 (en) 2015-09-10
BR112015022820A2 (pt) 2017-07-18
RU2015143177A (ru) 2017-04-18
EP2973135A1 (fr) 2016-01-20

Similar Documents

Publication Publication Date Title
CA2904418A1 (fr) Tests et procedes de selection d'un regime de traitement pour un sujet atteint de depression
KR102035877B1 (ko) 우울증이 있는 대상체를 위한 치료 양생법 선택을 위한 검정법 및 치료 방법
Stewart et al. Polymerase γ gene POLG determines the risk of sodium valproate‐induced liver toxicity
Claes et al. The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes
US20070254288A1 (en) Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
US8178299B2 (en) Method to determine the risk for side effects of an SSRI treatment in a person
WO2015136446A1 (fr) Méthodes de choix de traitement par antidépresseur pour traiter la dépression
US20160058766A1 (en) Assays and methods for selecting a treatment regimen for a subject with depression
Brodin Parkinson's disease and Gaucher disease: focus on the GBA1 link
US20100292339A1 (en) Genetic Polymorphisms Predictive of Nutritional Requirements for Choline in Subjects
NZ624231B2 (en) Assays and methods for selecting a treatment regimen for a subject with depression
Khorana A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department of Laboratory Medicine and Pathobiology
US20140187593A1 (en) Diagnostic test and treatment for a neurological disorder
Khorana Effects of folate deficiency on endothelial cell biology: Folate deficiency induces profound effects on global patterns of gene expression in vascular endothelial cells
Jacobson et al. INVITED SESSIONS
Hammons Genetic Polymorphisms and Antifolate Drug Treatment Can Alter Folate/Homocysteine Metabolism and Inflammatory Protein Profile

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190312